Analytical Data
-
Gene name
RC0497
- Application
-
Alternative Names
RC0497; Putative N-acetylmuramoyl-L-alanine amidase RC0497; EC 3.5.1.28
-
Species
Rickettsia conorii
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q92IC3
-
Expression Region
1-267aa
-
Molecular Weight
45.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RC0497 is a recombinant protein that has garnered attention in the field of biomedicine due to its potential applications in therapeutic interventions and diagnostics. This protein, derived from a specific gene sequence, has been engineered to exhibit unique properties that facilitate its interaction with various biological systems. Research on RC0497 explores its role in modulating immune responses, making it a candidate for vaccine development and cancer immunotherapy. The background of RC0497 research encompasses the pressing need for novel therapeutic agents that can effectively target diseases with unmet medical needs. The increased prevalence of various conditions, such as cancers and chronic infections, underscores the importance of understanding how engineered proteins like RC0497 can influence cellular mechanisms. By elucidating its structure-function relationships, scientists aim to optimize its efficacy and safety profiles. Additionally, ongoing studies focus on the protein's biochemical characteristics, metabolic pathways, and potential side effects, contributing to a comprehensive understanding of its therapeutic potential. Overall, RC0497 represents a promising avenue in protein engineering, reflecting broader trends in personalized medicine and innovative biotechnological approaches to health challenges.
